BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36344391)

  • 1. Oral and post-transplantation infectious status in patients with hematopoietic stem cell transplants: A prospective observational study.
    Sabancı A; Kuku İ
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2023 Feb; 135(2):242-248. PubMed ID: 36344391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral status of patients submitted to autologous hematopoietic stem cell transplantation.
    Fernandes LL; Torres SR; Garnica M; de Souza Gonçalves L; Junior AS; de Vasconcellos ÁC; Cavalcanti W; Maiolino A; de Barros Torres MC
    Support Care Cancer; 2014 Jan; 22(1):15-21. PubMed ID: 23975228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periodontal status and bacteremia with oral viridans streptococci and coagulase negative staphylococci in allogeneic hematopoietic stem cell transplantation recipients: a prospective observational study.
    Raber-Durlacher JE; Laheij AM; Epstein JB; Epstein M; Geerligs GM; Wolffe GN; Blijlevens NM; Donnelly JP
    Support Care Cancer; 2013 Jun; 21(6):1621-7. PubMed ID: 23288398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factor for death in hematopoietic stem cell transplantation: are biomarkers useful to foresee the prognosis in this population of patients?
    Massaro KS; Macedo R; de Castro BS; Dulley F; Oliveira MS; Yasuda MA; Levin AS; Costa SF
    Infection; 2014 Dec; 42(6):1023-32. PubMed ID: 25263811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of Febrile Neutropenia in Autologous Hematopoietic Stem Cell Transplant (HSCT) Recipients on levofloxacin prophylaxis.
    Signorelli J; Zimmer A; Liewer S; Shostrom VK; Freifeld A
    Transpl Infect Dis; 2020 Apr; 22(2):e13225. PubMed ID: 31785022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociations of oral foci of infections with infectious complications and survival after haematopoietic stem cell transplantation.
    Mauramo M; Grolimund P; Egli A; Passweg J; Halter J; Waltimo T
    PLoS One; 2019; 14(12):e0225099. PubMed ID: 31851665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Common oral diseases in allogeneic haematopoietic stem cell transplantation (HSCT) recipients pre-HSCT.
    Uutela P; Passweg J; Halter J; Weiger R; Waltimo T; Mauramo M
    Eur J Haematol; 2019 Apr; 102(4):351-356. PubMed ID: 30632215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of chemotherapy and hematopoietic stem cell transplantation pre and postterm DMFT scores: a preliminary study.
    Ertas ET; Kurnaz F; Zorba YO; Kocyigit I; Sisman Y; Kaynar L; Sekerci AE; Ertas H; Cetin M
    Niger J Clin Pract; 2014; 17(1):32-7. PubMed ID: 24326804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum procalcitonin as an independent diagnostic markers of bacteremia in febrile patients with hematologic malignancies.
    Yang M; Choi SJ; Lee J; Lee DG; Kim YJ; Park YJ; Oh EJ
    PLoS One; 2019; 14(12):e0225765. PubMed ID: 31821331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of sepsis biomarkers in hematopoietic stem cell transplant recipients in a condition of high prevalence of gram-negative pathogens.
    Stoma I; Karpov I; Uss A; Rummo O; Milanovich N; Iskrov I
    Hematol Oncol Stem Cell Ther; 2017 Mar; 10(1):15-21. PubMed ID: 27793578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The changing epidemiology of vancomycin-resistant Enterococcus (VRE) bacteremia in allogeneic hematopoietic stem cell transplant (HSCT) recipients.
    Kamboj M; Chung D; Seo SK; Pamer EG; Sepkowitz KA; Jakubowski AA; Papanicolaou G
    Biol Blood Marrow Transplant; 2010 Nov; 16(11):1576-81. PubMed ID: 20685257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
    Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breakthrough viridans streptococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients receiving levofloxacin prophylaxis in a Japanese hospital.
    Kimura M; Araoka H; Yoshida A; Yamamoto H; Abe M; Okamoto Y; Yuasa M; Kaji D; Kageyama K; Nishida A; Ishiwata K; Takagi S; Yamamoto G; Asano-Mori Y; Uchida N; Hishinuma A; Izutsu K; Wake A; Taniguchi S; Yoneyama A
    BMC Infect Dis; 2016 Aug; 16():372. PubMed ID: 27495798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piperacillin-tazobactam vs. imipenem-cilastatin as empirical therapy in hematopoietic stem cell transplantation recipients with febrile neutropenia.
    Jing Y; Li J; Yuan L; Zhao X; Wang Q; Yu L; Zhou D; Huang W
    Clin Transplant; 2016 Mar; 30(3):263-9. PubMed ID: 26701371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of procalcitonin and C-reactive protein as early diagnostic marker for the identification of transplant-related adverse events after allogeneic hematopoietic stem cell transplantation in pediatric patients.
    Cabanillas Stanchi KM; Queudeville M; Malaval C; Feucht J; Schlegel P; Dobratz M; Seitz C; Müller I; Lang P; Handgretinger R; Döring M
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2779-2791. PubMed ID: 31446489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
    Cohen S; Roy J; Lachance S; Delisle JS; Marinier A; Busque L; Roy DC; Barabé F; Ahmad I; Bambace N; Bernard L; Kiss T; Bouchard P; Caudrelier P; Landais S; Larochelle F; Chagraoui J; Lehnertz B; Corneau S; Tomellini E; van Kampen JJA; Cornelissen JJ; Dumont-Lagacé M; Tanguay M; Li Q; Lemieux S; Zandstra PW; Sauvageau G
    Lancet Haematol; 2020 Feb; 7(2):e134-e145. PubMed ID: 31704264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.
    Satlin MJ; Soave R; Racanelli AC; Shore TB; van Besien K; Jenkins SG; Walsh TJ
    Leuk Lymphoma; 2014 Dec; 55(12):2858-65. PubMed ID: 24559288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of specific pathogens to bloodstream infection mortality in neutropenic patients with hematologic malignancies: Results from a multicentric surveillance cohort study.
    Kern WV; Roth JA; Bertz H; Götting T; Dettenkofer M; Widmer AF; Theilacker C;
    Transpl Infect Dis; 2019 Dec; 21(6):e13186. PubMed ID: 31574202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology, management, and outcome of invasive fungal disease in patients undergoing hematopoietic stem cell transplantation in China: a multicenter prospective observational study.
    Sun Y; Meng F; Han M; Zhang X; Yu L; Huang H; Wu D; Ren H; Wang C; Shen Z; Ji Y; Huang X
    Biol Blood Marrow Transplant; 2015 Jun; 21(6):1117-26. PubMed ID: 25840339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The utility of routine chest radiography in the initial evaluation of adult patients with febrile neutropenia patients undergoing HSCT.
    Yolin-Raley DS; Dagogo-Jack I; Niell HB; Soiffer RJ; Antin JH; Alyea EP; Glotzbecker BE
    J Natl Compr Canc Netw; 2015 Feb; 13(2):184-9. PubMed ID: 25691611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.